Literature DB >> 10743452

The neuronal nitric oxide synthase inhibitor 7-nitroindazole (7-NI) and morphine act independently on the control of breathing.

L Teppema1, E Sarton, A Dahan, C N Olievier.   

Abstract

Inhibitors of nitric oxide synthase (NOS) have analgesic properties and reduce opioid tolerance and dependency. To investigate a possible interaction of NOS inhibitors with the respiratory depressant action of morphine, we determined the effects of the neuronal NOS inhibitor 7-nitroindazole (7-NI) on the ventilatory carbon dioxide response curve; subsequently, we studied the effects of additional morphine application. Finally, using naloxone, we investigated a possible interaction (at the opioid receptor) between the effects of 7-NI and morphine. The effects of 7-NI 50 mg kg-1 i.p., morphine 0.1 mg kg-1 i.v. and naloxone 0.1 mg kg-1 i.v. were studied using dynamic end-tidal carbon dioxide forcing in eight cats under alpha-choralose-urethane anaesthesia. Data analysis was performed using a two-compartment model comprising a fast peripheral and a slow central component characterized by carbon dioxide sensitivities and a single offset B (apnoeic threshold). 7-NI decreased the mean apnoeic threshold from 4.27 (SD 0.87) to 2.59 (1.71) kPa. Peripheral and central carbon dioxide sensitivities were reduced from 0.56 (0.22) to 0.26 (0.09) litre min-1 kPa-1 and from 0.09 (0.05) to 0.04 (0.03) litre min-1 kPa-1, respectively. Morphine increased the apnoeic threshold by 0.5 kPa and reduced carbon dioxide sensitivity by a further 35%. Naloxone reversed the ventilatory effects of morphine but not those induced by 7-NI. We conclude that the respiratory effects of 7-NI and morphine are mediated independently and that the effects of 7-NI do not result from interaction with opioid receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10743452     DOI: 10.1093/oxfordjournals.bja.a013402

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  7 in total

1.  Integrated characterization of the human chemoreflex system controlling ventilation, using an equilibrium diagram.

Authors:  Tadayoshi Miyamoto; Masashi Inagaki; Hiroshi Takaki; Toru Kawada; Yusuke Yanagiya; Masaru Sugimachi; Kenji Sunagawa
Journal:  Eur J Appl Physiol       Date:  2004-12       Impact factor: 3.078

2.  Exercise training augments neuronal nitric oxide synthase dimerization in the paraventricular nucleus of rats with chronic heart failure.

Authors:  Neeru M Sharma; Xuefei Liu; Tamra L Llewellyn; Kenichi Katsurada; Kaushik P Patel
Journal:  Nitric Oxide       Date:  2019-03-13       Impact factor: 4.427

3.  S-Nitroso-L-Cysteine Stereoselectively Blunts the Deleterious Effects of Fentanyl on Breathing While Augmenting Antinociception in Freely-Moving Rats.

Authors:  Paulina M Getsy; Santhosh M Baby; Ryan B Gruber; Benjamin Gaston; Tristan H J Lewis; Alan Grossfield; James M Seckler; Yee-Hsee Hsieh; James N Bates; Stephen J Lewis
Journal:  Front Pharmacol       Date:  2022-05-26       Impact factor: 5.988

Review 4.  Interactions between morphine and nitric oxide in various organs.

Authors:  Noboru Toda; Shiroh Kishioka; Yoshio Hatano; Hiroshi Toda
Journal:  J Anesth       Date:  2009-11-18       Impact factor: 2.078

5.  Interaction between the ventilatory and cerebrovascular responses to hypo- and hypercapnia at rest and during exercise.

Authors:  Shigehiko Ogoh; Naoyuki Hayashi; Masashi Inagaki; Philip N Ainslie; Tadayoshi Miyamoto
Journal:  J Physiol       Date:  2008-07-17       Impact factor: 5.182

6.  7-Nitroindazole and its rapidly emerging role in opioid pain management and withdrawal.

Authors:  Shailendra Kapoor
Journal:  J Blood Med       Date:  2012-05-09

7.  S-nitroso-L-cysteine stereoselectively blunts the adverse effects of morphine on breathing and arterial blood gas chemistry while promoting analgesia.

Authors:  Paulina M Getsy; Alex P Young; James N Bates; Santhosh M Baby; James M Seckler; Alan Grossfield; Yee-Hsee Hsieh; Tristan H J Lewis; Michael W Jenkins; Benjamin Gaston; Stephen J Lewis
Journal:  Biomed Pharmacother       Date:  2022-07-26       Impact factor: 7.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.